Multi-Parametric MRI for Renal Transplantation

Status Not yet recruiting

Clinical Trial Summary

The goals of this study are: - To optimize and evaluate multiple kidney MRI methods; and - To investigate the potential of MRI in the assessment of transplant kidney functions; To achieve these goals, we will perform pilot MRI studies with kidney transplant patients. We will study if MRI can reflect different levels of kidney function. The investigators will also evaluate if MRI can differentiate causes for declining kidney function. Finally, the investigators will explore how MRI measures changes before and after medical treatment for worsening kidney function. You may be invited for MRI exams with different exam options. An MRI exam may use either of two types of MRI machines at the center for magnetic resonance research (CMRR): the 3 Tesla (3T) scanner and the 7 Tesla (7T) scanner. You may also be invited for a multi-session exam. A description of the MRI exam types with different exam options and the types of multi-session exams is provided later in this document.

Clinical Trial Description

To achieve these goals, the investigators will perform pilot MRI studies with kidney transplant patients. The investigators will study if MRI can reflect different levels of kidney function. The investigators will also evaluate if MRI can differentiate causes for declining kidney function. Finally, the investigators will explore how MRI measures changes before and after medical treatment for worsening kidney function. Subjects may be invited for MRI exams with different exam options. An MRI exam may use either of two types of MRI machines at the CMRR: the 3T scanner and the 7T scanner. Subjects may also be invited for a multi-session exam. A description of the MRI exam types with different exam options and the types of multi-session exams is provided later in this document. ;

Study Design

Related Conditions & MeSH terms

Renal Transplant Rejection

Clinical Trial Details

NCT number	NCT03192007
Study type	Observational
Source	University of Minnesota
Contact
Status	Not yet recruiting
Phase
Start date	July 1, 2024
Completion date	December 31, 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03140514` - Urine CXCL10 Chemokine Monitoring Post-renal Transplant	N/A
Completed	`NCT02581436` - Testing Immunosuppression Threshold in Renal Allografts To Extend eGFR	N/A
Active, not recruiting	`NCT02409940` - To Elucidate the Effect of Mesenchymal Stem Cells on the T Cell Repertoire of the Kidney Transplant Patients	Phase 1
Completed	`NCT02377193` - Simulect Versus ATG in Sensitized Renal Transplant Patient	Phase 4
Completed	`NCT00771745` - Prospective Pilot Study of Pre-Transplant Thymoglobulin Administration in Living Donor Renal Transplant Recipients	Phase 4
Not yet recruiting	`NCT05385432` - Induction in Sensitized Kidney Transplant Recipients Without Pre-existing Donor-specific antiboDies	Phase 3
Completed	`NCT01953120` - Mechanisms of Belatacept Effect on Alloimmunity and Antiviral Response After Kidney Transplantation (BMS IM 103-309)	Phase 4
Terminated	`NCT01324934` - Efficacy and Safety of ATG-Fresenius Following a Renal Transplantation, Without Corticosteroids	Phase 3
Terminated	`NCT00983645` - A Trial Comparing Prograf and Neoral Use in Kidney Transplant Recipients of Hispanic Ethnicity	Phase 4
Active, not recruiting	`NCT04530630` - Switch to Bictegravir/Emtricitabine/Tenofovir Alafenamide After Renal Transplant	Phase 4
Recruiting	`NCT03707262` - Study of Combined Kidney and Blood Stem Cell Transplant From a Brother or Sister Donor	Phase 1/Phase 2
Completed	`NCT02006108` - Imaging Kidney Transplant Rejection Using Ferumoxytol-Enhanced Magnetic Resonance	N/A
Recruiting	`NCT03991780` - Fostamatinib in the Treatment of Chronic Active Antibody Mediated Rejection	Phase 1/Phase 2
Completed	`NCT02733029` - Contrast Enhanced Ultrasonography to Detect Human Renal Transplant Rejection	Phase 2
Active, not recruiting	`NCT02057965` - Mesenchymal Stromal Cell Therapy in Renal Recipients	Phase 2
Completed	`NCT00658073` - Induction Therapy With Autologous Mesenchymal Stem Cells for Kidney Allografts	N/A
Terminated	`NCT03646344` - Heme Arginate in Transplantation Study	Phase 3
Completed	`NCT02866682` - Prospective Study Comparing Brand and Generic Immunosuppression on Transplant Outcomes, Adherence, & Immune Response in Kidney Transplant Recipients	Phase 4
Not yet recruiting	`NCT06438107` - Deep Phenotyping of the Renal Allograft to Prognosticate Clinical Outcomes
Completed	`NCT02500251` - Belimumab Impacting Transplant Eligibility	Phase 1/Phase 2